Eupraxia Pharmaceuticals Statistics Share Statistics Eupraxia Pharmaceuticals has 35.85M
shares outstanding. The number of shares has increased by 0.64%
in one year.
Shares Outstanding 35.85M Shares Change (YoY) 0.64% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 27.7M Failed to Deliver (FTD) Shares 416 FTD / Avg. Volume 3.32%
Short Selling Information The latest short interest is 166.52K, so 0% of the outstanding
shares have been sold short.
Short Interest 166.52K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 15.55
Valuation Ratios PE Ratio 0 Forward PE -6.66 PS Ratio 0 Forward PS 17 PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Eupraxia Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.1,
with a Debt / Equity ratio of 0.
Current Ratio 11.1 Quick Ratio 11.1 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.13M Employee Count 33 Asset Turnover n/a Inventory Turnover n/a
Taxes Income Tax 48.26K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 97.06% in the
last 52 weeks. The beta is 1.54, so Eupraxia Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.54 52-Week Price Change 97.06% 50-Day Moving Average 4.89 200-Day Moving Average 3.75 Relative Strength Index (RSI) 50.37 Average Volume (20 Days) 12,532
Income Statement
Revenue n/a Gross Profit -209.91K Operating Income -37.2M Net Income -37.39M EBITDA -36.75M EBIT -36.9M Earnings Per Share (EPS) -1.58
Full Income Statement Balance Sheet The company has 33.1M in cash and 71.86K in
debt, giving a net cash position of 33.03M.
Cash & Cash Equivalents 33.1M Total Debt 71.86K Net Cash 33.03M Retained Earnings -131M Total Assets 29.23M Working Capital 26.41M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.99M
and capital expenditures -104.23K, giving a free cash flow of -30.1M.
Operating Cash Flow -29.99M Capital Expenditures -104.23K Free Cash Flow -30.1M FCF Per Share 0
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
